Furthermore, the ability to detect GSTP1 hypermethylation in non-invasive biological samples, such as blood or urine, offers the potential for developing non-invasive screening methods for early HCC detection (Zhang et al., 2022). The gene discussed is GSTP1; the disease is hepatocellular carcinoma.